Barclays initiated coverage of EssilorLuxottica (ESLOY) with an Overweight rating and EUR 305 price target The firm views EssilorLuxottica as a “quality compounder” with growth opportunities on lens differentiation, wearables and medical technology. The company’s vertical integration and positions across wholesale and retail “offer a robust competitive moat,” the analyst tells investors in a research note.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ESLOY:
- EssilorLuxottica’s Earnings Call Highlights Robust Growth
- EssilorLuxottica Reports Strong Growth in H1 2025
- EssilorLuxottica reports 1H revenue EUR 14.02B vs. EUR 13.29B last year
- EssilorLuxottica says AI glasses Ray-Ban Meta up more than 200% in sales in 1H
- EssilorLuxottica confirms target of mid single digit annual revenue growth